Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment - Archive ouverte HAL Access content directly
Journal Articles Clinical Gastroenterology and Hepatology Year : 2021

Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment

(1, 2) , (3) , (4) , (3) , (4) , (1, 2) , , , , , , , , , , , , , , , , , , , , , , , , (5, 6, 7) , , , (8, 9) , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
1
2
3
4
5
6
7
8
9
Nathalie Ganne-Carriè
  • Function : Author
Annalisa Berzigotti
  • Function : Author
Salvatore Petta
  • Function : Author
Sylvie Sacher Huvelin
  • Function : Author
Dominique Valla
  • Function : Author
Christophe Bureau
  • Function : Author
Anne Olivier
  • Function : Author
Frédéric Oberti
  • Function : Author
Jérôme Boursier
  • Function : Author
Jean Paul Galmiche
  • Function : Author
Jean Pierre Vinel
  • Function : Author
Clotilde Duburque
  • Function : Author
Alain Attar
  • Function : Author
Isabelle Archambeaud
  • Function : Author
Robert Benamouzig
Marianne Gaudric
  • Function : Author
Dominique Luet
  • Function : Author
Patrice Couzigou
  • Function : Author
Lucie Planche
  • Function : Author
Emmanuel Coron
  • Function : Author
Jean-Baptiste Hiriart
  • Function : Author
Faiza Chermak
  • Function : Author
Maude Charbonnier
  • Function : Author
Patrick Marcellin
  • Function : Author
Dominique Guyader
  • Function : Author
Hélène Fontaine
Dominique Larrey
Victor de Ledinghen
Denis Ouzan
Fabien Zoulim
Dominique Roulot
  • Function : Author
Albert Tran
  • Function : Author
Jean-Pierre Bronowicki
  • Function : Author
Jean-Pierre Zarski
  • Function : Author
Vincent Leroy
Ghassan Riachi
  • Function : Author
Paul Calès
Jean-Marie Péron
  • Function : Author
Laurent Alric
  • Function : Author
Marc Bourlière
  • Function : Author
Philippe Mathurin
  • Function : Author
Sebastien Dharancy
  • Function : Author
Jean-Frédéric Blanc
  • Function : Author
Armand Abergel
Lawrence Serfaty
Ariane Mallat
  • Function : Author
Jean-Didier Grangé
  • Function : Author
Pierre Attali
  • Function : Author
Yannick Bacq
  • Function : Author
Claire Wartelle
  • Function : Author
Thông Dao
Yves Benhamou
  • Function : Author
Christophe Pilette
  • Function : Author
Christine Silvain
Christos Christidis
Dominique Capron
  • Function : Author
Gérard Thiefin
  • Function : Author
Sophie Hillaire
  • Function : Author
Vincent Di Martino

Abstract

Background & aims: Based on platelets and liver stiffness measurements, the Baveno VI criteria (B6C), the expanded B6C (EB6C), and the ANTICIPATE score can be used to rule out varices needing treatment (VNT) in patients with compensated chronic liver disease. We aimed to improve these tests by including data on the ratio of platelets to liver stiffness. Methods: In a retrospective analysis of data from 10 study populations, collected from 2004 through 2018, we randomly assigned data from 2368 patients with chronic liver disease of different etiologies to a derivation population (n = 1579; 15.1% with VNT, 50.2% with viral hepatitis, 28.9% with nonalcoholic fatty liver disease, 20.8% with alcohol-associated liver disease, with model for end-stage liver disease scores of 9.5 ± 3.0, and 93.0% with liver stiffness measurements ≥10 kPa) or a validation population (n = 789). Test results were compared with results from a sequential algorithm (VariScreen). VariScreen incorporated data on platelets or liver stiffness measurements and then the ratio of platelets to liver stiffness measurement, adjusted for etiology, patient sex, and international normalized ratio. Results: In the derivation population, endoscopies were spared for 23.9% of patients using the B6C (VNT missed in 2.9%), 24.3% of patients using the ANTICIPATE score (VNT missed in 4.6%), 34.5% of patients using VariScreen (VNT missed in 2.9%), and 41.9% of patients using the EB6C (VNT missed in 10.9%). Differences in spared endoscopy rates were significant (P ≤ .001), except for B6C vs ANTICIPATE and in missed VNT only for EB6C vs the others (P ≤ .009). VariScreen was the only safe test regardless of sex or etiology (missed VNT ≤5%). Moreover, VariScreen secured screening without missed VNT in patients with model for end-stage liver disease scores higher than 10. This overall strategy performed better than a selective strategy restricted to patients with compensated liver disease. Test performance and safety did not differ significantly among populations. Conclusions: In a retrospective study of data from 2368 patients with chronic liver disease, we found that the B6C are safe whereas the EB6C are unsafe, based on missed VNT. The VariScreen algorithm performed well in patients with chronic liver disease of any etiology or severity. It is the only test that safely rules out VNT and can be used in clinical practice.

Dates and versions

hal-03258178 , version 1 (11-06-2021)

Identifiers

Cite

Arthur Berger, Federico Ravaioli, Oana Farcau, Davide Festi, Horia Stefanescu, et al.. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment. Clinical Gastroenterology and Hepatology, 2021, 19 (4), pp.777-787.e17. ⟨10.1016/j.cgh.2020.06.022⟩. ⟨hal-03258178⟩
40 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More